Curcumin nanoparticles: physicochemical fabrication, characterization, antioxidant, enzyme inhibition, molecular docking and simulation studies

Curcumin is an extensively studied natural compound due to its extensive biological applications. However, there are some drawbacks linked to this compound such as poor absorption, low water-solubility, quick systemic elimination, fast metabolism, poor pharmacokinetics, low bioavailability, low penetration targeting efficacy and low stability. To overcome these drawbacks, curcumin is encapsulated in nano-carriers. In the current studies, we synthesized nanoparticles of curcumin without using nanocarriers by different methods such as nano-suspension (Cur-NSM), sonication (Cur-SM) and anti-solvent precipitation (Cur-ASP) to enhance the solubility of curcumin in water. The prepared nanoparticles were characterized by FTIR, SEM and XRD analysis. These curcumin nanoparticles were screened for their solubilities in water, DPPH scavenging, amylase, α-glucosidase and β-glucosidase enzymatic activities. The particle size of nano-curcumin was found to be in the 47.4–98.7 nm range. The reduction in particle size of curcumin dramatically increases its solubility in water to 79.2 μg mL−1, whereas the solubility of curcumin is just 0.98 μg mL−1. Cur-ASP showed the highest free radical scavenging potential (48.84 ± 0.98%) which was comparable with standard BHT (50.48 ± 1.11%) at 75.0 μg mL−1. As well, Cur-ASP showed the highest inhibition of α-amylase (68.67 ± 1.02%), α-glucosidase (58.30 ± 0.52%), and β-glucosidase (64.80 ± 0.43%) at 100 μg mL−1 which is comparable with standard drug acarbose. The greater surface area of nanoparticles exposes the various groups of curcumin for blocking the binding sites of enzymes. This strategy may be helpful in designing curcumin as a potent therapeutic agent against diabetes mellitus. Further, the molecular interactions of curcumin with α-amylase, α-glucosidase, β-glucosidase, and polyphenol oxidase were assessed by analyzing the plausible binding modes of curcumin in the binding pocket of each receptor. The best binding mode of curcumin was used to make complexes with the target proteins and their stability was confirmed by 50 ns MD simulation.

[1]  M. Naseer,et al.  Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges. , 2023, European journal of medicinal chemistry.

[2]  Xiaoming Xu,et al.  Design and synthesis of novel benzimidazole-iminosugars linked a substituted phenyl group and their inhibitory activities against β-glucosidase. , 2022, Bioorganic chemistry.

[3]  Zhiguo Yu,et al.  Identification of raloxifene as a novel α-glucosidase inhibitor using a systematic drug repurposing approach in combination with cross molecular docking-based virtual screening and experimental verification. , 2021, Carbohydrate research.

[4]  R. Rajapakse,et al.  Synthesis of Curcumin Nanoparticles from Raw Turmeric Rhizome , 2021, ACS omega.

[5]  K. Byrappa,et al.  A review on medicinal plants evaluated for anti-diabetic potential in clinical trials: Present status and future perspective , 2021 .

[6]  Saghir Ahmad,et al.  A green ultra‐fast liquid chromatographic method for quantification of curcumin in extract of Curcuma longa L. followed by confirmation via spectroscopic techniques , 2021 .

[7]  A. A. Oroojan,et al.  Antioxidant Effects of Eugenol on Oxidative Stress Induced by Hydrogen Peroxide in Islets of Langerhans Isolated from Male Mouse , 2020, International journal of hepatology.

[8]  K. Skonieczna-Żydecka,et al.  Antioxidant Potential of Curcumin—A Meta-Analysis of Randomized Clinical Trials , 2020, Antioxidants.

[9]  I. Kaur,et al.  Enhancing Bioavailability and Stability of Curcumin Using Solid Lipid Nanoparticles (CLEN): A Covenant for Its Effectiveness , 2020, Frontiers in Bioengineering and Biotechnology.

[10]  M. El-Naggar,et al.  Curcumin nanoparticles have potential antioxidant effect and restore tetrahydrobiopterin levels in experimental diabetes. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  Xin-Qiu Yao,et al.  The Bio3D packages for structural bioinformatics , 2020, Protein science : a publication of the Protein Society.

[12]  Yi Wang,et al.  Scalable molecular dynamics on CPU and GPU architectures with NAMD. , 2020, The Journal of chemical physics.

[13]  O. Çiftçi,et al.  A novel and green nanoparticle formation approach to forming low-crystallinity curcumin nanoparticles to improve curcumin’s bioaccessibility , 2019, Scientific Reports.

[14]  B. Salehi,et al.  Antidiabetic Potential of Medicinal Plants and Their Active Components , 2019, Biomolecules.

[15]  M. González-Torres,et al.  Formulations of Curcumin Nanoparticles for Brain Diseases , 2019, Biomolecules.

[16]  Abdullah M. Asiri,et al.  Sulfonamides containing curcumin scaffold: Synthesis, characterization, carbonic anhydrase inhibition and molecular docking studies. , 2018, Bioorganic chemistry.

[17]  A. Hameed,et al.  Screening of curcumin‐derived isoxazole, pyrazoles, and pyrimidines for their anti‐inflammatory, antinociceptive, and cyclooxygenase‐2 inhibition , 2018, Chemical biology & drug design.

[18]  A. Hameed,et al.  Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase , 2017, Acta pharmaceutica.

[19]  Abdullah M. Asiri,et al.  Azomethines, isoxazole, N-substituted pyrazoles and pyrimidine containing curcumin derivatives: Urease inhibition and molecular modeling studies. , 2017, Biochemical and biophysical research communications.

[20]  Rahila Huma,et al.  Atomic absorption and inductively coupled plasma–optical emission spectroscopic method for determination of micronutrients and toxic metals in Curcuma longa L. to characterize human health toxicity , 2017 .

[21]  Carmay Lim,et al.  How Molecular Size Impacts RMSD Applications in Molecular Dynamics Simulations. , 2017, Journal of chemical theory and computation.

[22]  O. Erbaş,et al.  Accumulation of α-Synuclein in Cerebellar Purkinje Cells of Diabetic Rats and Its Potential Relationship with Inflammation and Oxidative Stress Markers , 2017, Neurology research international.

[23]  Muhammad Imtiaz Shafiq,et al.  Synthesis, characterization, biological activities and molecular modeling of Schiff bases of benzene sulfonamides bearing curcumin scaffold , 2016, Arabian Journal of Chemistry.

[24]  Ata-ur-Rehman,et al.  High rate capability and long cycle stability of Cr2O3 anode with CNTs for lithium ion batteries , 2016 .

[25]  M. Ramirez-Tortosa,et al.  Curcumin and Health , 2016, Molecules.

[26]  H. Park,et al.  Enhancement of Curcumin Solubility by Phase Change from Crystalline to Amorphous in Cur-TPGS Nanosuspension. , 2016, Journal of food science.

[27]  David R Webb,et al.  Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective , 2015, Postgraduate Medical Journal.

[28]  Zhou Zhu,et al.  Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility , 2015, PloS one.

[29]  M. Jaggi,et al.  Therapeutic Applications of Curcumin Nanoformulations , 2015, The AAPS Journal.

[30]  G. Jagetia,et al.  Curcumin Stimulates the Antioxidant Mechanisms in Mouse Skin Exposed to Fractionated γ-Irradiation , 2015, Antioxidants.

[31]  James Andrew McCammon,et al.  Effects of histidine protonation and rotameric states on virtual screening of M. tuberculosis RmlC , 2013, Journal of Computer-Aided Molecular Design.

[32]  Lin Li,et al.  Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods , 2012, Journal of Nanoparticle Research.

[33]  L. Gordon,et al.  Curcumin nanodisks: formulation and characterization. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[34]  Rupesh Kumar Basniwal,et al.  Curcumin nanoparticles: preparation, characterization, and antimicrobial study. , 2011, Journal of agricultural and food chemistry.

[35]  B. M. Pinto,et al.  New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. , 2010, Biochemistry.

[36]  I. Gülçin,et al.  Antioxidant and radical scavenging properties of curcumin. , 2008, Chemico-biological interactions.

[37]  R. Robertson,et al.  Pancreatic islet β‐cell and oxidative stress: The importance of glutathione peroxidase , 2007, FEBS letters.

[38]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[39]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[40]  L. Griensven,et al.  An insight into antidiabetic properties of six medicinal and edible mushrooms: Inhibition of α-amylase and α-glucosidase linked to type-2 diabetes , 2019, South African Journal of Botany.